ID   Scid.adh
AC   CVCL_B7SC
SY   SCID.adh
DR   ABM; T8203
DR   Lonza; 69
DR   Wikidata; Q114312960
RX   PubMed=10452996;
RX   PubMed=15882585;
CC   Sequence variation: Mutation; MGI; MGI:104779; Prkdc; Simple; p.Tyr4046Ter (c.12138T>A) (Prkdc(scid)); Zygosity=Homozygous (from inference of genetic background of Scid mice).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C.B.-17-scid (CB17/Icr-Prkdcscid/IcrIcoCrl).
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 02-05-24; Version: 5
//
RX   PubMed=10452996; DOI=10.4049/jimmunol.163.5.2576;
RA   Carleton M., Ruetsch N.R., Berger M.A., Rhodes M., Kaptik S.,
RA   Wiest D.L.;
RT   "Signals transduced by CD3epsilon, but not by surface pre-TCR
RT   complexes, are able to induce maturation of an early thymic lymphoma
RT   in vitro.";
RL   J. Immunol. 163:2576-2585(1999).
//
RX   PubMed=15882585; DOI=10.1016/j.ydbio.2005.01.027;
RA   Dionne C.J., Tse K.Y., Weiss A.H., Franco C.B., Wiest D.L.,
RA   Anderson M.K., Rothenberg E.V.;
RT   "Subversion of T lineage commitment by PU.1 in a clonal cell line
RT   system.";
RL   Dev. Biol. 280:448-466(2005).
//